2019
DOI: 10.1016/j.biopha.2019.108776
|View full text |Cite
|
Sign up to set email alerts
|

Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(30 citation statements)
references
References 54 publications
0
30
0
Order By: Relevance
“…Based on the classification in previous experiments, the process of pulmonary fibrosis is divided into two stages. The early stage is the inflammatory phase, at around 0-7 days after bleomycin administration, while the later stage is the fibrotic phase, starting from 7 days of bleomycin administration [26]. According to these information, we checked the severity of pulmonary fibrosis at day 14 but explored the effects of PM on inflammatory phases by specifically evaluating the changes in immune cell number and profile in BALF between days 2 and 7.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the classification in previous experiments, the process of pulmonary fibrosis is divided into two stages. The early stage is the inflammatory phase, at around 0-7 days after bleomycin administration, while the later stage is the fibrotic phase, starting from 7 days of bleomycin administration [26]. According to these information, we checked the severity of pulmonary fibrosis at day 14 but explored the effects of PM on inflammatory phases by specifically evaluating the changes in immune cell number and profile in BALF between days 2 and 7.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of BML-induced lung injury is not entirely clear, but likely includes components of oxidative damage, relative deficiency of the deactivating enzyme BML hydrolase, genetic susceptibility, and elaboration of inflammatory cytokines. Oxidative damage to the lung appears important in the pathophysiology of lung injury, and antioxidants may ameliorate the process [19]. Systemic administration of antioxidant artemisitene strongly inhibits bleomycin-induced lung damage, through the activation of the Nrf2 signaling pathway [20].…”
Section: Bleomycin-induced Toxicitymentioning
confidence: 99%
“…However, different exposures might cause lung fibrosis through distinct mechanisms. Small molecules, such as bleomycin, might induce fibrosis by primarily inducing tissue damage through metabolic stress [ 32 ]. This, consequently, activates the immune system as a secondary event.…”
mentioning
confidence: 99%